We are currently seeking a Student Assistant QM* to strengthen our CQA/ QMS department. You will work in Tübingen (Germany).
You work in an interdisciplinary environment with colleagues from Germany and Houston (TX) and take on administrative tasks in the area of document management and the quality management system. Through your pro-active thinking and acting, your organizational skills and your commitment, you contribute to the team's success.
Your main responsibilities will include but are not limited to the following tasks:
- Maintenance and administration of the QM databases
- Support of the CQA/ QMS team in organizational and administrative tasks
- Filing/ archiving of documents and folders
- Coordination of the Immatics archive
We are a committed and inspired team and cherish the collegial, highly motivated and family-friendly atmosphere within Immatics. As a Student Assistant*, you can work flexible hours, which makes it easy to combine your work at Immatics with your studies. In addition, we offer you the opportunity to gain practical experience and to establish valuable contacts for your future career. With us, you will gain an insight into the working methods and requirements of a growing biotech company in a dynamic working environment.
*We value diversity and inclusion. Immatics N.V. and all Immatics subsidiaries are equal opportunity employers that evaluate qualified applicants without regard to race, color, national origin, religion, sex, age, marital status, disability, veteran status, sexual orientation, gender identity, or other characteristics protected by law.
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.
This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.